ASML’s €45 Billion Forecast Collides With a Congressional Gamble
Published on 07/24/2026 at 18:31 | Redaktion boerse-global.de
On a day when the broader tech sector lurched lower and the Nasdaq shed 2.15 percent, ASML barely flinched. The Dutch lithography giant’s shares edged up 0.11 percent to €1,584.80, a quiet defiance that stood out against the market’s jitters over rising oil prices and a hawkish Federal Reserve. For a stock that has already surged nearly 72 percent this year, the calm was telling.
Yet beneath that surface stability, two powerful forces are pulling the narrative in opposite directions. One is a demand boom so intense that ASML has raised its 2026 revenue outlook for the second time this year, now targeting €43 billion to €45 billion, up sharply from the €36 billion to €40 billion range it flagged in April. The other is a piece of draft legislation in Washington — the MATCH Act — that could sever roughly a fifth of that revenue by blocking exports of advanced chip-making equipment to China.
Intel’s Spending Pledge Adds a Layer of Protection
Just days after ASML’s quarterly update, Intel provided a fresh dose of reassurance. On July 23, the US chipmaker reported a 25.4 percent revenue jump in the second quarter and, more critically for ASML, raised its 2026 capital expenditure forecast from $18 billion to $20 billion. Intel is pushing ahead with its 18A-P and 14A process technologies, and Tesla has already signed on as a foundry customer for the 14A node.
That spending directly feeds ASML’s order book. The most advanced lithography systems — the kind that cost hundreds of millions of euros each — are not discretionary purchases. They are the physical backbone of the semiconductor industry’s race to sub-2-nanometer nodes. As long as Intel, TSMC, and Samsung keep investing, ASML’s monopoly on extreme ultraviolet (EUV) lithography ensures it captures the bulk of that spending.
Should investors sell immediately? Or is it worth buying Asml?
CEO Christophe Fouquet described the first-half order intake as “extraordinarily strong,” with customers accelerating their capacity plans. For the third quarter alone, ASML expects revenue of €11 billion to €12 billion, a jump of more than 20 percent from the €9.3 billion it reported in the prior quarter.
The China Question Won’t Go Away
The political risk, however, remains unresolved. In early April, US lawmakers introduced the MATCH Act, a bill designed to halt shipments of advanced chip-making equipment to China. The legislation has yet to pass through Congress, and no new restrictions are currently in force beyond existing rules. ASML already does not ship its most cutting-edge machines to China. But CFO Roger Dassen has said the country will still account for roughly 20 percent of group revenue in 2026.
That exposure is the central tension. A enacted law would carve directly into that revenue stream. JPMorgan analyst Sandeep Deshpande estimates that if restrictions come, earnings per share could fall by as much as 10 percent, with sales to other regions only partially offsetting the loss. Degroof Petercam had previously modeled low-single-digit percentage revenue declines under a similar scenario.
Morningstar analyst Javier Correonero points to a paradoxical dynamic from past episodes: fear of restrictions has historically prompted Chinese customers to stockpile machines, creating a short-term demand surge. That pattern could repeat if the MATCH Act gains momentum, but it would merely pull forward sales rather than create new ones.
A Stretched Valuation Leaves Little Room for Error
The stock’s current price — around €1,566 — sits 10.4 percent below its June record of €1,748. Even after that pullback, the shares trade 31.7 percent above their 200-day moving average, with a 30-day annualized volatility of 55.5 percent. After a 153.5 percent rally over the past twelve months, the stock is acutely sensitive to headlines.
The monopoly that makes ASML indispensable also makes it a political target. Its EUV machines are the most complex manufacturing tools on the planet, and their strategic importance means any shift in export policy draws immediate attention. The same pricing power that underpins margins also invites regulatory scrutiny.
Asml at a turning point? This analysis reveals what investors need to know now.
Where the Next Catalyst Comes From
For the bull case to hold, two things need to happen. First, the order momentum and capacity expansion must stay on track. ASML plans to boost its low-NA EUV capacity from roughly 65 systems in 2026-2027 by 30 percent, and is studying a further increase of the same magnitude for 2028. Second, the MATCH Act must stall in Congress — or at least emerge in a form that carves out existing commercial relationships.
The bear case is simpler: if the bill passes, the China revenue assumption in the 2026 guidance collapses, and a stock trading well above its moving averages will reprice quickly. The key support level to watch is €1,529.30, the 50-day moving average. As long as that holds, the combination of rising industry capex and institutional buying — Arrowstreet Capital recently boosted its stake by 6.3 percent to a position worth over $2 billion — provides a floor.
The next major trigger is not a single earnings date. It is the legislative calendar in Washington, running in parallel with ASML’s ability to execute its capacity roadmap through 2027 and beyond. The order book is full, the technology is irreplaceable, and the demand is real. But the stock’s next leg will be decided as much by politics as by physics.
Ad
Asml Stock: New Analysis - 24 July
Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
